Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models

Authors

K. J. Brennand, Icahn School of Medicine at Mount Sinai
J Xu
B. J. Hartley, Icahn School of Medicine at Mount Sinai
P. Kurup, Yale University
A. Phillips, Hussman Institute for Autism
A. Topol, Icahn School of Medicine at Mount Sinai
M Xu
C. Ononenyi, Yale University
E. Foscue, Yale University
S. M. Ho, Icahn School of Medicine at Mount Sinai
T. D. Baguley, Yale University
N. Carty, Yale University
C. S. Barros, Peninsula Medical School
U. Müller, University of Florida
S. Gupta, Cincinnati Children's Hospital Medical Center
P. Gochman, National Institutes of Health
J. Rapoport, National Institutes of Health
J. A. Ellman, Yale University
C. Pittenger, Yale University
B. Aronow, Cincinnati Children's Hospital Medical Center
A. C. Nairn, Yale University
M. W. Nestor, Hussman Institute for Autism
P. J. Lombroso, Yale University

ORCID

• C. S. Barros: 0000-0003-0361-0333

DOI

10.1038/mp.2016.163

Publication Date

2016-10-18

Publication Title

Molecular Psychiatry

ISSN

1359-4184

Recommended Citation

Brennand, K., Xu, J., Hartley, B., Kurup, P., Phillips, A., Topol, A., Xu, M., Ononenyi, C., Foscue, E., Ho, S., Baguley, T., Carty, N., Barros, C., Müller, U., Gupta, S., Gochman, P., Rapoport, J., Ellman, J., Pittenger, C., Aronow, B., Nairn, A., Nestor, M., & Lombroso, P. (2016) 'Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models', Molecular Psychiatry, . Available at: https://doi.org/10.1038/mp.2016.163